Summit Investment Advisors Inc. Grows Holdings in Maximus, Inc. (NYSE:MMS)

Summit Investment Advisors Inc. lifted its stake in shares of Maximus, Inc. (NYSE:MMS - Free Report) by 51.9% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 28,133 shares of the health services provider's stock after acquiring an additional 9,607 shares during the period. Summit Investment Advisors Inc.'s holdings in Maximus were worth $2,100,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. UMB Bank n.a. lifted its stake in Maximus by 79.8% during the fourth quarter. UMB Bank n.a. now owns 356 shares of the health services provider's stock worth $27,000 after purchasing an additional 158 shares during the last quarter. Eastern Bank purchased a new position in shares of Maximus during the 4th quarter valued at about $29,000. V Square Quantitative Management LLC lifted its position in Maximus by 65.9% in the 4th quarter. V Square Quantitative Management LLC now owns 453 shares of the health services provider's stock worth $34,000 after buying an additional 180 shares during the last quarter. R Squared Ltd purchased a new stake in Maximus in the fourth quarter worth approximately $54,000. Finally, IFP Advisors Inc grew its position in Maximus by 62.4% during the fourth quarter. IFP Advisors Inc now owns 786 shares of the health services provider's stock valued at $59,000 after acquiring an additional 302 shares during the last quarter. 97.21% of the stock is currently owned by hedge funds and other institutional investors.

Maximus Trading Down 0.1 %

MMS traded down $0.09 on Friday, hitting $67.29. 360,597 shares of the company were exchanged, compared to its average volume of 551,316. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.72 and a current ratio of 1.72. The firm has a fifty day simple moving average of $67.60 and a two-hundred day simple moving average of $75.18. The stock has a market capitalization of $3.81 billion, a PE ratio of 14.47 and a beta of 0.68. Maximus, Inc. has a 12 month low of $63.77 and a 12 month high of $93.97.

Maximus (NYSE:MMS - Get Free Report) last issued its earnings results on Thursday, February 6th. The health services provider reported $1.61 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.39 by $0.22. Maximus had a net margin of 5.28% and a return on equity of 21.95%. Sell-side analysts expect that Maximus, Inc. will post 6.15 earnings per share for the current year.

Maximus Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Saturday, May 31st. Stockholders of record on Thursday, May 15th will be paid a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a dividend yield of 1.78%. The ex-dividend date is Thursday, May 15th. Maximus's dividend payout ratio (DPR) is 25.81%.

Insider Transactions at Maximus

In other Maximus news, insider Ilene R. Baylinson sold 14,500 shares of the company's stock in a transaction on Wednesday, February 19th. The shares were sold at an average price of $68.14, for a total value of $988,030.00. Following the completion of the transaction, the insider now directly owns 2,512 shares in the company, valued at approximately $171,167.68. This represents a 85.23 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Jan Madsen sold 2,439 shares of Maximus stock in a transaction dated Tuesday, March 18th. The shares were sold at an average price of $67.71, for a total transaction of $165,144.69. Following the sale, the director now directly owns 18,097 shares in the company, valued at $1,225,347.87. The trade was a 11.88 % decrease in their position. The disclosure for this sale can be found here. 1.60% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on MMS. Raymond James raised shares of Maximus from a "market perform" rating to an "outperform" rating and set a $90.00 price objective for the company in a research note on Thursday, January 2nd. StockNews.com lowered shares of Maximus from a "buy" rating to a "hold" rating in a research report on Friday, February 14th.

Maximus Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.